Therapeutic Group: Anti Bacterial Presentation Rifamax 200 tablet: Each tablet contains Rifaximin BP 200 mg. Rifamax 550 tablet: Each tablet contains Rifaximin BP 550 mg. Description Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic. Very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered […]
Therapeutic Group: Anti Viral Presentation Celbarin: Each capsule contains Ribavirin BP 200 mg. Description Ribavirin is a nucleoside analogue with antiviral activity. Indications Ribavirin is indicated in combination with peg-interferon alpha-2a, 2b or interferon alpha injection for the treatment of chronic hepatitis C in patients with compensated liver disease previously untreated with alpha interferon or […]
Therapeutic Group: Skin Presentation Retapex ointment: Each gram ointment contains Retapamulin INN 10 mg. Description Retapamulin is a semi-synthetic pleuromutilin antibiotic. It is active against Staphylococcus aureus as well as Streptococcus pyogenes organisms. Retapamulin is bacteriostatic at minimum inhibitory concentration (MIC) against these pathogens. The bactericidal concentration against relevant pathogens is 1,000 times of the […]
Therapeutic Group: Anti Diabetic Presentation Nomopil 0.5 : Each tablet contains Repaglinide USP 0.5 mg. Nomopil 1 : Each tablet contains Repaglinide USP 1 mg. Nomopil 2 : Each tablet contains Repaglinide USP 2 mg. Description Repaglinide is an oral blood glucose-lowering drug of the meglitinide class used in the management of Type 2 diabetes […]
Therapeutic Group: µ-opioid agonisTherapeutic Group: µ-opioid agonis Presentation Remifen Injection: Each vial contains Remifentanil Hydrochloride BP equivalent to Remifentanil 1 mg as lyophilized powder. Description Remifentanil Hydrochloride is a µ-opioid agonist with rapid onset and peak effect and short duration of action. The µ-opioid activity of Remifentanil Hydrochloride is antagonized by opioid antagonists such as […]
Therapeutic Group: Anti Viral Presentation Ninavirâ„¢ 100 IV Infusion: Each vial contains Remdesivir INN 100 mg as lyophilized powder Description Remdesivir is a prodrug of a modified adenine nucleoside analog. Remdesivir undergoes efficient metabolic conversion in cells and tissues to active nucleoside triphosphate metabolite that inhibits viral RNA polymerases. Remdesivir is highly selective for viral […]
Therapeutic Group: Gynaecological Presentation RehanzilTM : Each Tablet contains Relugolix INN 40 mg, Estradiol BP 1 mg & Norethindrone Acetate USP 0.5 mg. Description Rehanzil is a combination of Relugolix, Estradiol (E2), and Norethindrone Acetate (NETA). Relugolix is a non-peptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors, thereby reducing the release of […]
Therapeutic Group: Others Presentation Rexilo 120: Each tablet contains Relugolix 120 mg. Description Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors, thereby, reducing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and consequently testosterone. Indications Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment […]
Therapeutic Group: Kinase inhibitor Presentation Regocent : Each tablet contains Regorafenib Monohydrate INN eq. to Regorafenib 40 mg. Description Regorafenib is a kinase inhibitor and it inhibits multiple membrane-bound and intracellular kinases involved in normal cellular functions and in pathologic processes such as oncogenesis, tumor angiogenesis, and maintenance of the tumor microenvironment. Regorafenib or its […]
Therapeutic Group: Cardiovascular Presentation Ranolazine 500 SR tablet: Each film-coated sustained release tablet contains Ranolazine INN 500 mg. Description Ranolazine has anti-ischemic and anti-angina effects that do not depend upon reduction in heart rate or blood pressure. It does not affect the rate-pressure product, a measure of myocardial work, at maximal exercise. Ranolazine at therapeutic […]